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FOREWORD
Substance abuse and addiction is an equal opportunity problem. Old and young, rich
and poor are equally vulnerable to its effects on their health. In order to improve the health
and well-being of our nation’s citizens, we need to recognize the universality of the effects of
substance abuse and mount an all-fronts attack on all abuse of legal and illegal drugs, alcohol,
and tobacco.
The central missions of CASA--the Center on Addiction and Substance Abuse at
Columbia University--are to identify the cost of substance abuse throughout American society
and inform the American people of those costs and the impact of substance abuse on their
lives: to find out what works in prevention and treatment; and to encourage all individuals and
institutions to take responsibility to deal with substance abuse.
For almost two years, funded by the Henry J. Kaiser Family Foundation, CASA has
been engaged in the first analysis ever undertaken of the cost of substance abuse to the nation’s
health care system. The initial phase of this project, completed in July of 1993, examined the
effect of substance abuse on inpatient Medicaid hospital costs.In that tudy, CASA found that
one in five hospital days and $7.4 billion of Medicaid inpatient hospital costs in 1994, will be
linked with the use or abuse of alcohol, tobacco or drugs.
This second report documents the impact on the Medicare hospital program. Nearly
one out of every four dollars Medicare spends on inpatient hospital care, and one out of every
five Medicare hospital admissions, are attributable to substance abuse. From cancer to stroke
and heart disease, from respiratory infections to injuries and accidents, the use and abuse of
cigarettes, alcohol, pills and drugs is a major cause of many diseases that eventually result in
hospitalizations for which Medicare pays. In 1994 dollars, substance abuse will cost Medicare
$20 billion in inpatient hospital costs alone.
These numbers are low. Research documenting the health effects of alcohol and
drugs on the elderly has not been a high priority and studies of the effects of abuse of
prescription drugs are nearly non-existent.Even for cigarettes, where there is a substantial
body of research on health effects, much of it ignores the elderly and the accumulated
consequences of smoking for decades, which affects the elderly disproportionately. Physicians
underreport the incidence of alcohol and drug abuse in the elderly population more so than in
the younger population. Concern about patient confidentiality and embarrassment leads many
doctors to fail to record alcohol and drug problems.Physicians often misperceive
disorientation or incoherence caused by alcohol or drugs as a symptom of the. natural aging
process or dementia.
For Medicare, the biggest culprit in causing poor health is tobacco, accounting for
nearly 80% of substance abuse-related Medicare hospitalizations. Again, this may be because
we do not know enough about the health effects of alcohol and drugs.But it also reflects the
high prevalence of long-term smoking among the elderly. More than 36% of Medicare
recipients are former smokers and nearly 20% currently smoke. Three out of five current
smokers and one third of the quitters smoked more than 10 cigarettes a day for more than 35
years.
Perhaps the most disturbing finding of this study is that substance abuse will cost
the Medicare program one trillion dollars over the next 20 years. On April 21, the trustees of
the Medicare Trust Fund released a report predicting that the Fund would run out of money
in seven years.Inevitably, the politicians responded with proposals to raise taxes, increase
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premiums, and/or cut benefits. In all the discussions about rising Medicare costs, little
attention focused on how to prevent hospitalizations altogether.A ten percent reduction in the
amount of substance abuse would save the Trust Fund $100 billion over the next 20 years.
This study was conducted by CASA under the direction of Jeffrey Merrill, Vice
President for Policy and Research and a professor at Columbia University School of Public
Health, and Kimberley Fox, senior program manager, with the assistance of Han hua Chang,
Gerald Pulver and Dr. Andrew Schiff. Their research could not have been accomplished
without the valuable advice. of a number of distinguished physicians, epidemiologists, and
economists. For their continued assistance and consultation on this entire project to identify
the cost of substance abuse to the health care system, I would especially like to thank Jeffrey
Kelman, M.D. and Dorothy Rice, ScD.
By the end of the year, CASA will complete its assessment of the impact of
substance abuse on the entire health care system and will release a report covering the entire
system-- private sector hospitalizations as well as outpatient and long term care.
Joseph A. Califano, Jr.
Chairman and President
. . .
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THE IMPACT OF SUBSTANCE ABUSE ON MEDICAFtE  INPATIENT HOSPITAL COSTS
INTRODUCTION
The Annual Report of the Trustees of the Federal Hospital Insurance Trust Fund
released in April 1994 projected that the Medicare program will run out of money in seven
years. This projection of future insolvency for the Fund--which pays the vast majority of
hospital costs for the elderly and disabled--is due in large part to the fact that Medicare
payments for hospital costs continue to grow at an alarming rate, outstripping the revenues paid
into the Fund.
In responding to this crisis, invariably, the proposed solutions involve raising taxes
or cutting benefits. In all these discussions, however, little time is spent in thinking about how
we can keep elderly ‘people healthy and avert hospitalizations.The worst ‘example of this is
our failure to move aggressively on the pervasive impact of substance abuse, including
tobacco, alcohol and drugs, on both Medicare and overall health costs. Based on our findings,
$20 billion 1994 inpatient Medicare hospital payments will be due to substance abuse and
addiction.If the problems of substance abuse did not exist, we would not now be concerned
about the solvency of the Hospital Trust Fund. Over the next seven years, substance abuse will
cosf the Trust Fund almost $170 billion. For future generations worried about the continued
survival of this program, over the next 20 years, Medicare will pay out more than $1 trillion
for hospital care related to substance abuse.
Past studies I-3 have provided evidence of the impact of substance abuse on health
care. Further, these studies have tended to underestimate the full magnitude of the problem
because they either focus on only one substance or have not taken full advantage of the
epidemiologic research that relates substance abuse to virtually every major disease category.
Despite such limitations, these studies still provide a powerful argument for the inclusion of
substance abuse in the cost containment debate. In addition, they demonstrate the need to
understand more fully just how critical this issue is if we are to address seriously not only the
concerns over the solvency of the Medicare Trust Fund, but health care reform in general.
The CASA Study
In 1992, CASA--The Center on Addiction and Substance Abuse at Columbia
University--initiated a comprehensive study documenting the full extent to which all substance
abuse, including alcohol, drugs and tobacco, contributes to the costs of the health care system.
Combining a critical review of the medical and epidemiologic literature linking substance abuse
as a risk factor for a wide variety of medical conditions, with extensive consultation with
physicians and researchers knowledgeable in this area, CASA is in the process of estimating
the magnitude of this problem and its associated costs.
The first phase of this project, which examined the extent to which Medicaid
hospital costs might be attributed directly or indirectly to substance abuse, was completed in
July of 1993.4 This study found that at least one in five hospital days under Medicaid, or $7.4
billion of Medicaid hospital costs in 1994, could be linked with the use or abuse of alcohol,
tobacco or drugs.For diseases and health conditions as disparate as cancer, stroke, heart
disease, AIDS, trauma, and birth complications, substance abuse has been documented to be
a major risk factor. When these health effects are considered, substance abuse takes a major
toll on the Medicaid program. And these estimates are undoubtedly still low because of both
the underreporting of the problem and the fact that the available research, particularly for
alcohol and drugs, is incomplete in documenting the full impact of substance abuse on
morbidity.
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In addition, while many had argued that the effects of these substances on disease
were long-term, and the results of efforts to control abuse and addiction would not be seen for
many years, the CASA study found the opposite to be the case.In fact, two-thirds of the costs
of substance abuse to Medicaid were related to short-term health problems including those
associated with trauma, AIDS and birth complications, where the impact on health can be seen
almost immediately. Efforts to control the use of these substances can lead to immediate
savings to the health care system.
The current phase of CASA’s work.deals with the impact of substance abuse on the
use of inpatient hospital services under Medicare. As suggested in a recent study reported in
the Journal of the American Medical Association3 which examined alcohol-related
hospitalizations in the elderly, the costs of alcohol abuse to Medicare can be significant.But,
when all substances--as well as all the health problems related to them--are considered, the
costs to Medicare are astronomically higher: more than 50 times as much as was estimated in
that earlier study. Using the methodology from the previous CASA study of Medicaid
(described in Appendix I), but accounting for the differential impact of these substances on the
elderly, as with Medicaid, substance abuse proved to be a major contributor both to morbidity
and to the costs of health care for the elderly and disabled.
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The HighCost of Substance Abuse
RESULTS
In 1991”, there were 2.2 million tobacco, alcohol, or drug-related Medicare
admissions which accounted for 20% of all Medicare hospitalizations. Because these substance
abuse-related cases tend to be more expensive to treat than the average hospital case, the
amount actually paid out by Medicare for substance abuse-related care was even higher,
accounting for 23% or nearly one-fourth of the total Medicare payments for hospital care.b
Substance abuse-related cases cost more to treat because they required almost 26% more
hospital staff and other resources than Medicare discharges that are unrelated to substance
abuse. We estimated that Medicare discharges for conditions where substance abuse was a
major risk factor had a Case Mix Index (CMI - a measure of resource use) of about 1.51,
compared to a CMI of 1.21 for diagnoses not related to substance abuse.
As displayed in Graph 1, in dollars, Medicare spent over $13 billion of its $57
billion inpatient short-stay hospital expenditures on substance abuse-related care. These
amounts exceed the 1 out of 5 dollars spent in the Medicaid program for substance-abuse
related conditions.
Based upon these results, it is estimated that, for 1994, substance abuse-related
Medicare hospital costs will rise to $20 billion. These costs include substance abuse-related
care for both elderly and disabled Medicare recipients, with the disabled comprising 12% of
these costs.
a 1991 is the most recent year that National Hospital Discharge Survey data is available.
bSee Methods section for discussion of how payments were calculated.
Graph 1
As can be seen in Table 1, the largest share of Medicare inpatient substance abuse
costs--$12.5 billion or 97% of the total--was for medical treatment of illnesses and conditions
attributable to the abuse of alcohol, drugs and tobacco. These are conditions that do not
mention substance abuse in the diagnosis, but are ones that have been repeatedly shown in
epidemiologic research to be associated with the use of at least one of these substances.
In contrast, treatment for conditions that explicitly mention alcohol or drug abuse
account for only 4% of all substance abuse-related discharges, consuming 3% of those costs.
This low percentage of alcohol and drug diagnoses is misleading, and is probably more
reflective of a reluctance by physicians to classify the elderly population as alcohol or drug
dependent, than an indication of a low prevalence of alcohol or drug use among the elderly and
disabled. Underreporting .of substance abuse as either a primary or secondary condition for this
population is clearly a problem as depicted in Graph 2. While 5% of all Medicare beneficiaries
are considered heavy drinkers and 3% report using drugs (see Table 2), only 3% of Medicare
patients in the hospital had a diagnosis that mentioned either alcohol or drug use or both.
Since alcohol and drug users tend to be at greater risk for medical care, we would expect them
to make up a larger, not smaller, proportion of the hospitalized population. In fact, separate
studies measuring alcoholism alone among the hospitalized elderly indicate that 9-20% actually
have a drinking problem.5*6This wide range in estimates of alcohol problems suggest that
identification of alcoholism varies considerably across physicians. Thus, relying solely on
diagnoses that explicitly mention alcohol or drugs on the medical record in order to measure
the prevalence and cost of drugs and/or alcohol problems in hospitals grossly underestimates
the full impact of substance abuse on Medicare costs.
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Drug use among the elderly also accounted for a very small percentage of the total
discharges, even though more than 3% of this population admit to using drugs in the last year.
This low number is, in part, indicative of a lack of research connecting illicit drugs with
disease, and does not imply that drugs present no problem for the elderly. Further, since we
were also unable to find sufficient data from the epidemiologic literature to quantify the health
effects of the abuse of prescription drugs, we could not estimate the extent of that problem
either. Thus, our estimate of the impact of drugs--both legal and illicit--on Medicare is
undoubtedly low. There is clearly a need for more research to understand and quantify the
impact of all drugs on morbidity and cost.Since the elderly are such large users of
prescription drugs, this research is even more critical with respect to that population.
In total, we found more than 60 conditions that are associated with substance abuse
covering virtually every major disease category (Appendix 1I)c. In the Medicare population,
more than half of the substance abuse-related hospital admissions were for cardiovascular
diseases, 15% for respiratory diseases, 12% for neoplasms, and 7% for burns and trauma
(Table 3). These results differ somewhat from the earlier Medicaid study where the adverse
impact on birth outcomes represented the major contributor to the costs attributable to the
substance abuse. Further, in comparing substance abuse problems in the Medicaid and
Medicare populations, the impact on Medicare was much more a result of the long-term effects
of smoking. More than 80% of substance abuse-related Medicare hospital costs was for
treating smoking-related medical conditions-- fr m lung cancer to chronic pulmonary
‘This number is lower than the 72 substance-abuse related conditions identified in the
Medicaid because further analysis led us to combine some specific diagnoses into broader
diagnostic categories. Appendix II provides an even more detailed breakdown of the substance
abuse-related discharges in all the conditions identified.
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Table 3
obstruction disease (COPD) to coronary artery disease, as opposed to only 40% for the
predominantly younger, Medicaid population.
The Medicare population is at a much higher risk for getting smoking-related
diseases because people over 65 who have smoked tend to have done so more heavily and for
longer time periods. Nearly 3 out of 5 of current Medicare smokers (58%) and almost one
third of former smokers (32.7%) smoked an average of more than 10 cigare tes per day for
over 35 years (Graph 3).
Substance Abuse as a ComplicatingFactor in the Treatmentof other Diseases
When substance abuse isr corded as a secondaryiagnosis to an otherwise
unrelated condition, it tends to complicate and prolong the treatment for the underlying
problem. On average, a secondary diagnosis of alcohol and/or drug abuse increased the length
of time patients stay in the hospital. Compared to Medicare patients with the same primary
diagnoses, those with a secondary diagnosis of substance abuse stayed an average of more than
a half a day longer, 9.3 days compared with 8.6 days. While this is not insignificant, the
marginal effect of substance abuse as a secondary diagnosis in the Medicare population is
much smaller than what was found for Medicaid, where substance abusers stayed twice as long
as non-substance abusers.
This small differential between length of stay for Medicare patients with and without
substance abuse problems is most likely a significant underestimate of the full effect of alcohol
and drugs as a complication. Many cases that actually involved alcohol or drug problems were
not recorded as having this secondary diagnosis.Since, n our analysis, these cases would be
counted in the non-substance abuse group, they may be artificially inflating the length of stay
for that group. If the secondary diagnosis of substance abuse had been correctly noted, the
7
Graph 3
difference between the two groups would have been greater. Nevertheless, despite this
problem, complications resulting from a secondary diagnosis of substance abuse accounted for
$108 million in added cost to Medicare.
These figures represent average lengths of stay in Medicare but, for some diseases,
the difference in length of stay was much higher. For example, for patients with pancreatitis,
those requiring major joint and limb reattachments, and those with pathological fractures with
a secondary diagnosis of substance abuse, patients stayed approximately twice as long as their
non-substance abusing counterparts (pancreatitis 17 days vs. 8 days; major joint 24 vs. 10;
pathological fractures 17 vs. 10) (Graph 4).
However, for other diseases, the ALOS was, in fact, shorter for some Medicare
patients with a secondary diagnosis of substance abuse. For example, patients with respiratory
infections and intlarnmations,cellulitis, and GI obstruction, who also had a secondary
diagnosis of substance abuse, stayed less time in the hospital than non-substance abusers (e.g.,
respiratory infections 8.4 days vs. 11.7 days, cellulitis 7.4 vs. 8.6, and GI obstruction 3.7 vs.
7.4) This does not mean that patients with substance abuse needed less care. There are several
possible explanations for why these substance abusers had shorter lengths of stay. It may
result’ from an aberration in the data due to the small sample size of patients within these
diagnoses, or because of the premature departure caused by some patients signing out against
medical advice. -However, it may also reflect the financial or social undesirability to hospitals
of many of these patients which, in turn, may lead to their early discharge or transfer to
another facility.In this context, it is worth noting that, if this hypothesis is true, as the forces
of competition in health care intensify, these results suggest that such “undesirable” patients
may be increasingly pushed out prematurely from some institutions.Further, the nature of the
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DRG payment itself-- with an implicit limit on the days of covered care--also may work
against patients with substance abuse as a complicating factor to another health problem. Far
more research is needed in this area.
While this study , focused on substance abuse in short stay general hospitals,
Medicare also pays a significant amount in psychiatric hospital costs. According to a survey.
of psychiatric hospitals, 15.6 percent of total admissions were for alcohol and drug abuse-
related disorders. This does not include cases where another diagnosis may have been recorded
or the substance abuse was secondary to a mental health problem.But, applying this
percentage to Medicare psychiatric costs, in 1991 Medicare spent an additional $160 million
on care for substance abuse in psychiatric hospitals.
C O N C L U S I O N
Substance abuse is a pervasive problem that is not limited to one segment of our
society. Rather, old and young and rich and poor are all equally vulnerable to its effects on
their health. Further, substance abuse cannot be viewed only as a single disease entity, but
must be considered as a problem that permeates every aspect of our health system and is a risk
factor for all major disease categories.Not only must physicians concerned with addiction .
medicine address this issue, but all physicians, regardless of specialty, must be aware of the
fact that alcohol, tobacco and drugs are a major factor in both
medical problems of their patients.Thus, physicians--as
professionals--must be both capable of, and willing to identify
steps necessary to address it. This may range from discussions
substance abuse problems to referral to appropriate treatment.
causing and complicating the
well as other health care
substance abuse and take the
with the r patients about their
9
But, the problem does not rest solely upon the shoulders of health care providers.
What has been sorely needed in the discussions of how to contain health care costs is a
discussion of how we can improve our health and reduce the morbidity that leads to those
costs. To do so, we need to acknowledge the importance of substance abuse as a major factor
in causing and complicating the health problems of our citizens. As a nation, we have not yet
made the commitment to address the problem of substance abuse. For example, the U.S. is the
only industrialized nation among a group surveyed which had a tobacco tax that amounted to
less than 50% of the cost of a pack of cigarettes.U.S. total taxes amounted to only an average
of 30%. In addition, most other countries have considerably greater regulation on all forms
of tobacco advertising than does the U.S. Among 19 countries rated in terms of their control
of advertising, the U.S. ranked 18th.’
Nor have we invested sufficiently in the research necessary to identify and target
effective interventions, or even to understand fully the relationship between various substances
and illness.As we found in our own work, while there has been extensive epidemiologic
research linking cigarette smoking and a variety of diseases, fewer studies relate alcohol to
disease, and even less is known about the full impact of illegal drugs.
#ether, in the end, we discover that substance abuse is responsible for 20 or 30
percent (or more) of health care costs may be less the issue than the fact that we already know
that literally hundreds of billions of dollars are spent each year on health care as a result of
substance abuse. As a result, the future solvency of the Medicare Trust Fund is inextricably
intertwined with what we do today to reduce substance abuse in all its forms--among our
citizens. Preventing diseases that result from substance abuse and prolonging a healthy life for
the elderly can be a much more potent weapon against rising Medicare expenditures than the
10
multitude of other, more frequently discussed cost-containment measures or benefit reductions.
If there were no substance abuse, the Trust Fund’s solvency would not be in doubt for almost
twice the period than the Trustees are now projecting.
But this issue extends beyond the Medicare program. Debating the broader issues
surrounding health care reform without either acknowledging the impact of substance abuse,
or including the prevention and treatment of this problem an integral part of that reform, will
be a costly mistake, making it impossible to provide universal access at all; or at a cost that,
as a nation, we can afford.
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APPENDIX I: METHODS
The methodology for this study relied primarily on the existing epidemiologic
literature, as well as on consultations with physicians knowledgeable about substance abuse and
related disorders.
Epidemiologic Literature Search
We conducted a Medline search of epidemiologic or etiologic studies that identified
substance abuse (tobacco, alcohol, or drugs). as a major risk factor for acquiring a given
disease/condition. In this search, we selected individual studies, reviews, or meta-analyses, that
quantified either a relative risk or an attributable risk, and that generally met the criterion
established by the Surgeon General for establishing causality. * Specifically, we favored studies
that 1) reported stratified relative risks by levels of consumption or by age and sex, 2)
demonstrated a dose-response relationship, 3) found diminishment of risk upon cessation of
use, and 4) had findings that were generally consistent with other studies. In addition, with
a very few exceptions, we used studies that measured the abusers’ increased risk of acquiring
a disease relative to a non-substance abuser (morbidity studies), as opposed to their increased
risk of dying of the disease (mortality studies).
Studies that were reviews or me&analyses of other studies took priority since they
combined the results of multiple studies and often reported a composite attributable or relative
risk. If these were not available, we selected large prospective or case-control studies and
calculated an average relative risk from these studies.When po sible, we selected studies that
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were targeted at the elderly population. However, we found that the elderly population is not
often the focus of medical or epidemiologic research. In lieu of elderly-specific relative risks,
we used relative risks for the general adult population.
Population Attributable Ribk
Relative risks in epidemiologic studies are calculated by dividing the incidence of
disease in the exposed group by the incidence in the disease in the non-exposed group.’ Some
researchers go one step further and calculate the risk, not just for the individual, but to the
larger community, by measuring the Population Attributable Risk (PAR). The PAR is the
proportion of cases for a given disease that may be attributable to an etiologic factor (e.g.
cigarette smoking) and is calculated using the following formula:9
PAR=e-11 xl()o
b(r-I)+1
where b = prevalence of substanceuse in the population
r = relative risk for a givendisease
For each disease or medical conditionwhere a substance abuser’s relative risk was
reported in the epidemiologic literature, wecalculated a Medicare-specific population
attributable risk (PAR) using relative risks reported in the studies and the specific prevalence
estimates for tobacco, alcohol, and drugs in the Medicare population. Appendix II provides
a listing of those conditions, the related substances and their PARS. The PAR was computed
using the above formula or, where different relative risks were reported by current and former
users or by level of consumption, the PAR formula was revised to reflect this specificity.
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Where diseases had joint multiple PARs for different substances (smoking and alcohol), the
alcohol PAR was weighted by a factor of 0.5.
For the Medicare population, we used a prevalence of 9% for heavy drinking based
on studies of drinking in the hospitalized elderly population.The prevalence of drug use was
obtained from the 1991 National Household Drug Survey, and smoking from the 1987 National
Medical Expenditures Survey. For most smoking-related diseases, we calculated PARS using
prevalences for current and former smokers with their respective relative risks (see TABLE 4
in Results). However, for malignant neoplastic disease, some scientific evidence suggests that
once smokers have reached a certain threshold of smoking (more than 10 cigarettes per day
for more than 35 years), their relative risk is not diminished by cessation.” Smoking over a
long period of time may have an irreversible oncogenic effect which is not altered by
quitting.“*‘2For the Medicare population over 65 we found that 32.7% of former smokers
meet the criterion of having smoked more than 10 cigarettes per day for more than 35 years.
For this reason, we considered this subset of former smokers to be equivalent to current
smokers in the PAR calculations for cancer.
Once PARs were computed for all diseases and conditions, ICD-9-CM codes were
matched to the general diagnostic categories used in much of the epidemiologic literature. For
example, the lung cancer category included ICD-9 codes 162.2-.9 (malignant neoplasms of the
bronchus and lung). However, if the ICD-9 codes were not specifically identified in the
original study, with the assistance of a medical coder and several physician consultants, we
selected ICD codes that fell into the general disease classification and then matched the PARs
for that disease category with the associated ICD-9 codes (see Appendix II).
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Table 5
For those ICD-9 codes which explicitly mention alcohol or drug abuse in their titles,
we assigned a PAR of lOO%, since all of these hospital days are attributable to substance
abuse. In addition, the NIAAA  has identified a list of diagnoses that are completely alcohol-
related (e.g. cirrhosis). These diagnoses were also assigned a PAR of 100% (Table 5).
The costs to Medicare of substance abuse treatment in psychiatric hospitals was also
included in the study. This was derived from data collected by the National Association of
Psychiatric Health Systems on both the. use of drug and alcohol services and the prevalence of
Medicare discharges.”
Database
To determine the Medicare hospital costs for treating substance abuse-related
illnesses, we used Medicare data reported on the 1991 National Hospital Discharge Survey
(NHDS). The NHDS is a nationwide sample survey of short-stay hospitals. Each NHDS
record includes the patient’s primary payer, demographic information, principal diagnosis and
up to four secondary diagnoses (reported by
length of stay.
ICD-9 codes), DRG category, procedures, and
Extracting all Medicare dischargesthat had a primary diagnosis that fell within a
given ICD-9 code for which we had a PAR, we then applied each PAR (by age or sex, if
applicable) to the discharges with corresponding diagnoses. For example, approximately
111,000 Medicare hospital discharges had lung cancer as their primary diagnosis. Of these,
87% (the PAR) or 96,600 hospitalizations were attributed to smoking.
Since Medicare pays on the basis of DRGs (not diagnoses), it was necessary to
analyze the data by DRGs to estimate the costs of these substance abuse-related admissions to
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Medicare. For example, Medicare discharges that had a primary diagnosis of lung cancer fell
into any one of 8 DRGs (depending on the procedure required or other complications) and,
therefore, were paid a different amotmt depending on the DRG. By placing the discharges
calculated above for each ICD-9 code into their appropriate DRG, we were able to adjust for
the case mix index (CMI), or the relative payment level for that discharge. In this way, we
were able to obtain a case-mix adjusted total for substance abuse-attributable discharges. We
then multiplied these weighted discharges by the standardized national average DRG payment
for 1991 ($3,974) to determine total Medicare substance abuse costs.
While adjusting for CMI allows us to capture the higher cost per discharge for
certain diagnoses, it does not measure the differential impact on length of stay when substance
abuse is recorded as a secondary diagnosis.To capture the incremental costs of substance
abuse as a complicating factor in treating conditions unrelated to substance abuse, we also
analyzed the marginal impact of substance abuse as a secondary diagnosis on hospital length
of stay. For this analysis, we defined substance abuse as only those diagnoses that explicitly
mention drug or alcohol use (e.g. alcohol poisoning) or that are the immediate reaction to
substance use (e.g. delirium tremens).
We calculated the difference in length of stay for patients with and without these
substance abuse secondary diagnoses that had the same primary diagnoses (by gender and for
the under 65 and over 65 age groups) to determine the marginal days of care that were
substance-abuse related. Estimating an average cost of $604 per day for these extra days, we
then added these incremental costs to our total.
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APPENDIX II
MEDICARE ICD9 CODE/PAR LIST
Disease Abused
Category Substance ICD-9 Codes
AIDS
Neoplasms
Bladder Cancer S 188.0-188.9, 233.7
Breast Cancer A
Cervical Cancer S
Cheek and Gum CancerSLT
Colorectal Cancer A, S
Esophageal Cancer A,s
Laryngeal Cancer A S 161.0-161.9, 231.0
Leukemia S 204.0-208.9
Liver Cancer A 155.0-155.2, 230.8
Lung cancer s, PS 162.2-162.9, 231.2
Oral/Pharyngeal Cancer A, S, SLT
Pancreatic Cancer
Prostate Cancer S 185, 233.4
Renal Cancer S 189.0, 233.9
Renal Pelvis Cancer S 189.1
Salivary Gland CancerSLT 142.0-142.9
Stomach Cancer S 151.0-151.9, 230.2
Ureter Cancer- S
Vulvar Cancer S
Cancer, General S
IV D
IV D
S
042.0-044.9
174.0-174.9, 233.0
180.0-180.9, 233.1
143.0-143.9, 1450,234.S
153.0-153.9, 154.0-154.1
230.3-230.4
150.1-150.9, 230.1
140.0-141.9, 143.0-149.9,
230.0
157, 230.9
189.2
184.0-l 84.9
V073, V66.2, 198.89, 199
V58.1
PAR
32% ~13
55% <I3
49% M
39% F
15%
28% F
86%
33% M
18% F
100% M
97% F
100%
20%
18%
93% M
83% F
100% M
82% F
37% M
31% F
7% M
43% M
17% F
62%
10%
35% M
28% F
71%
24%
54% M
22% F
17
Respiratory Disease
COPD S
Influenza S
Other respiratory dis. S
Pneumonia
Cardiovascular Disease
Cardiomyopathy
Cerebrovascular Disease
Coronary Artery DiseaseS
Coronary Heart Disease
Endocarditis
Hypertension
Peripheral Vascular Dis.
PrCgnancy Complications
Placentae Previa
Premature Rupture S
Spontaneous Abortion
Preteen Delivery
Newborns
Congenital Anomalies
S
A
S, D
S
IV D
A
S
S
s, c
S
S
491.0-492.9, 493.2, 494, 86% M
496 74% F
487.0-487.1 30%
510.9, 511.0-511.9 37% M
512.0-512.8, 513.0, 518.0, 35% F
518.3, 518.81, 518.82
480.1-480.8, 481 .O, 482.1- 29% M
482.9, 483, 485, 486
425.1, 425.4, 425.9 37% M
431.0-435.9 70% M ~65
73% F <65
33% M 65+
16% F 65+
410.0-410.9, 411.1-411.9, 64%
413.0-413.09, 413.2-414.09,
414.2-414.9, 427.41, 429.2-429.29,
427.41, 429.71, 429.79
413.1, 414.1, 427.1, 427.41,
427.5-427.69, 427.71, 429.79,
428.0-428.19, 428.9, 429.3
421.0, 421.9
401.0-401.9, 402.0-402.9
403.0-403.9, 404.0-404.9
642.0, 642.2, 642.9
415.1, 416.9, 440.0-448.9
451.0-451.9, 453.1-453.9,
454.0-454.9
18% M
31% F
75%
18%
75%
641.0-641.1, 762.0 26% F
658.11, 658.13,658.2, 761.1 32% F
634 37% F
644.0-644.9, 656.3-656.6 18% F
740.0-759.9 20%
IV D = INTRAVENOUS DRUG USE; S = S MOKING; A=ALCOHOL; SLT =
SMOKELESS TOBACCO; PS = PASSIVE SMOKE.
.* 18
Low Birth Weight
Congenital Syphilis
Digestive System
Cirrhosis
Crohn’s Disease
Duodenal Ulcers
Pancreatitis, Acute A
Pancreatitis, Chronic
Peptic Ulcers
Stomach Ulcers
Endocrine and Metabolic
Diabetes
Other
S 764.0-765.9 36%
S 090.0-090.9 18%
A 571.5
S 555.0-555.9
A, s 532.00-532.90
A
577.0
A, S
S
S
A, S
A
577.1
533
531
72%
32%
46% M
3% F
44%
90% M
33% F
25% M
14% F
29% M
8% F
S 250.0 4% F
Burns A, S, D
Cataract S
Dementia A, D
Epilepsy A
Hepatitis A IV D
Hepatitis B IV D
Hepatitis C IV D
Low Back Pain S
Pelvic Inflammatory Dis. S
Peridonitis s
Seizures A
Trauma - A, D
Tuberculosis A
940.0-949.9
366.1,366.3,366.45,366.9
290.1,290.2,290.3,290.4,
294.1, 294.9
345.1,345.3,345.9
70.1
70.2, 70.3
70.51, 70.59, 70.9
724.2,724.5,724.8,724.9
614-616
522.4, 523.4
780.3
800.0-909.9, 921 .O-939.9
950.0-959.9
011-013, 017, 018
23%
3% M
2% F
11%
27%
6%
12%
36%
5%
38% F
40%
22%
25%
25%
Diseases Entirely Related to Substance Abuse
IV D = IN TR A VE NOUS D RUG U S E; S = SM O K I N G; A = AL C O H O L; SLT =
S M O KE LESS T O B A C C O; PS = PASSIVE S M O K E.
19
Alcohol Related A
Drug Related D
291, 303, 980, 950, 357.5, 425.5, 100%
535.3, 571.0-571.3, 655.4, 760.71,
790.3, 11.3, 61.41, 70.4, 79.1,
860.1, 860.2, 860.8, 860.9
292, 304, 962, 965, 967, 968, 969, 100%
970, 971, 977, 850-854, 357.6,
648.3, 655.5, 760.7, 779.4-779.5,
858.0, 858.8, 858.9
IVD = I NTRAVENOUS DRUG USE; S =SMOKING; A=ALCOHOL; SLT=
SMOKELESS TOBACCO; PS =PASSIVE S MOKE.
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